| pubmed-article:19672212 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0019159 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0062527 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C1442162 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0805586 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0205453 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C1550718 | lld:lifeskim |
| pubmed-article:19672212 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:19672212 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:19672212 | pubmed:dateCreated | 2010-2-3 | lld:pubmed |
| pubmed-article:19672212 | pubmed:abstractText | A total of 465 children aged 8 to 10 years were vaccinated with 2 doses of Recombivax-HB 2.5 microg (RB) or Twinrix-Junior 10 microg/360 EL.U (TX), according to a 0 and 6 months schedule. Seven years postsecond dose, a challenge dose of vaccine was given. All vaccinees in the TX and 98% in the RB group showed an anamnestic response. Vaccination at the age of 8 to 10 years with two-pediatric doses of TX or RB given with a 6 months interval induces a long-lasting immunity in most vaccinees. | lld:pubmed |
| pubmed-article:19672212 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19672212 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19672212 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19672212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19672212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19672212 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19672212 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:19672212 | pubmed:issn | 1532-0987 | lld:pubmed |
| pubmed-article:19672212 | pubmed:author | pubmed-author:MurphyDonaldD | lld:pubmed |
| pubmed-article:19672212 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:19672212 | pubmed:author | pubmed-author:BoulianneNico... | lld:pubmed |
| pubmed-article:19672212 | pubmed:author | pubmed-author:DionneMarcM | lld:pubmed |
| pubmed-article:19672212 | pubmed:author | pubmed-author:GilcaVladimir... | lld:pubmed |
| pubmed-article:19672212 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19672212 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:19672212 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19672212 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19672212 | pubmed:pagination | 916-8 | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:meshHeading | pubmed-meshheading:19672212... | lld:pubmed |
| pubmed-article:19672212 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19672212 | pubmed:articleTitle | Long-term immunogenicity of two pediatric doses of combined hepatitis A and B or monovalent hepatitis B vaccine in 8 to 10-year-old children and the effect of a challenge dose given seven years later. | lld:pubmed |
| pubmed-article:19672212 | pubmed:affiliation | Quebec National Public Health Institute, Quebec, Canada. vladimir.gilca@ssss.gouv.qc.ca | lld:pubmed |
| pubmed-article:19672212 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19672212 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
